Prostate Cancer - Results from #27080

Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: An early sign of invasion and hormone-refractory cancer? - Abstract November 2, 2011

MicroRNAs associated with metastatic prostate cancer - Abstract November 2, 2011

Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: A nested case-control study in UK primary care - Abstract November 2, 2011

Biochemical outcome after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy: 12 Years of experience - Abstract November 2, 2011

Characterisation and manipulation of Docetaxel resistant prostate cancer cell lines - Abstract November 2, 2011

The metabolic syndrome and risk of prostate cancer in Italy - Abstract November 2, 2011

Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses - Abstract November 2, 2011

Overall and worst Gleason scores are equally good predictors of prostate cancer progression - Abstract November 1, 2011

Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: A validation study - Abstract November 1, 2011

4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery - Abstract November 1, 2011

Predictive value of positive surgical margins after radical prostatectomy for lymph node metastasis in locally advanced prostate carcinoma - Abstract November 1, 2011

Electronic portal imaging vs kilovoltage imaging in fiducial marker image guided radiotherapy for prostate cancer: An analysis of set-up uncertainties - Abstract November 1, 2011

Dasatinib combined with docetaxel for castration-resistant prostate cancer: Results from a phase 1-2 study - Abstract November 1, 2011

Importance of multiparametric magnetic resonance tomography for prostate cancer - Abstract November 1, 2011

Abiraterone acetate: In metastatic castration-resistant prostate cancer - Abstract November 1, 2011

Editor's Commentary - A population-based analysis of temporal perioperative complication rates after minimally invasive radical prostatectomy November 1, 2011

Surgery for high-risk localized prostate cancer - Abstract October 31, 2011

Focal therapy for prostate cancer - where are we in 2011? - Abstract October 31, 2011

Validation of the Prostate Cancer Risk Index (PRIX): A simple scoring system to predict risk of biochemical relapse after radical prostatectomy for prostate cancer - Abstract October 31, 2011

Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study - Abstract October 31, 2011

Page 1355 of 1447